IL-12 and IL-18 act in synergy to clear vaccinia virus infection: Involvement of innate and adaptive components of the immune system

Journal of General Virology

Volumn 84, Issue 8, 2003, Pages 1961-1972

  Gherardi, M Magdalena ^a   Ramírez, Juan C ^a,b   Esteban, Mariano ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 12; INTERLEUKIN 18;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; CELLULAR IMMUNITY; CLEARANCE; CONTROLLED STUDY; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNE SYSTEM; INOCULATION; LYMPHOCYTE DEPLETION; MOUSE; NATURAL KILLER CELL; NONHUMAN; OVARY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SCID MOUSE; SPLEEN; T LYMPHOCYTE; TH1 CELL; VACCINIA VIRUS; VIRAL GENE DELIVERY SYSTEM; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS RECOMBINANT;

ANIMALS; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; DRUG SYNERGISM; FEMALE; IMMUNITY, NATURAL; INTERLEUKIN-12; INTERLEUKIN-18; KILLER CELLS, NATURAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, SCID; OVARY; RECOMBINATION, GENETIC; SPLEEN; T-LYMPHOCYTES; VACCINIA; VACCINIA VIRUS;

ANIMALIA; DNA VIRUSES; VACCINIA VIRUS;

EID: 0043169587     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.19120-0     Document Type: Review

References (55)

1. Boelen, A., Kwakkel, J., Barends, M., de Rond, L., Dormans, J. & Kimman, T. (2002). Effect of lack of interleukin-4, interleukin-12, interleukin-18 or IFN-γ receptor on virus replication, cytokine response, and lung pathology during respiratory syncytial virus infection in mice. J Med Virol 66, 552-560.
2. Bohn, E., Sing, A., Zumbihi, R., Bielfeldt, C., Okamura, H., Kurimoto, M., Hessemann, J. & Autenrieth, I. B. (1998). IL-18 (IFN-γ-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J Immunol 160, 299-307.
3. Bowie, A., Kiss-Toth, E., Symons, J. A., Smith, G. L., Dower, S. K. & O'Neill, L. A. J. (2000). A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc Natl Acad Sci U S A 97, 10162-10167.
4. Cai, G., Radzanowski, T., Villages, E. N., Kastelein, R. & Hunter, C. A. (2000). Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii. J Immunol 165, 2619-2627.
5. Cavanaugh, V. J., Guidotti, L. G. & Chisari, F. V. (1997). Interleukin 12 inhibits hepatitis B virus replication in transgenic mice. J Virol 71, 3236-3243.
6. Coughlin, C. M., Salhany, K. E., Wysocka, M. & 7 other authors (1998). Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J Clin Invest 101, 1441-1452.
7. Coutelier, J. P., Van Broeck, J. & Wolf, S. F. (1995). Interleukin-12 gene expression after viral infection in the mouse. J Virol 69, 1955-1958.
8. Dallo, S. & Esteban, M. (1987). Isolation and characterization of attenuated mutants of vaccinia virus. Virology 159, 408-422.
9. Dinarello, C. A., Novick, D., Puren, A. J. & 7 other authors (1998). Overview of interleukin-18: more than an interferon-γ inducing factor. J Leukoc Biol 63, 658-664.
10. Dybing, J. K., Walters, N. & Pascual, D. W. (1999). Role of endogenous IL-18 in resolving wild-type and attenuated Salmonella typhimurium infections. Infect Immun 67, 6242-6248.
11. Fujioka, N., Akazawa, R., Ohashi, K., Fujii, M., Ikeda, M. & Kurimoto, M. (1999). Interleukin-18 protects mice against acute herpes simplex virus type I infection. J Virol 73, 2401-2409.
12. Fukao, T., Matsuda, S. & Koyasu, S. (2000). Synergistic effects of IL-4 and IL-18 on IL-12-dependent IFN-γ production by dendritic cells. J Immunol 164, 64-71.
13. Gazzinelli, R. T., Giese, N. A. & Moore, H. C. R., III (1994). In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS). J Exp Med 180, 2199-2208.
14. Gherardi, M. M., Ramirez, J. C., Rodriguez, D., Rodriguez, J. R., Sano, G., Zavala, F. & Esteban, M. (1999). IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner. J Immunol 162, 6724-6733.
15. Gherardi, M. M., Ramírez, J. C. & Esteban, M. (2001). Towards a new generation of vaccines: the cytokine IL-12 as an adjuvant to enhance cellular immune responses to pathogens during prime-booster vaccination regimens. Histol Histopathol 16, 655-667.
16. Harandi, A. M., Svennerholm, B., Holmgren, J. & Eriksson, K. (2001). Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of acquired gamma interferon-mediated protective immunity. J Virol 75, 6705-6709.
17. Hodges, J. L., Ireland, D. D. & Reiss, C. S. (2001). The role of interleukin-18 in vesicular stomatitis virus infection of the CNS. Viral Immunol 14, 181-191.
18. Hofstra, C. L., Van Ark, I., Hofman, G., Kool, M., Nijkamp, F. P. & Van Oosterhout A. J. M. (1998). Prevention of Th2-like cell responses by coadministration of IL-12 and IL-18 is associated with inhibition of antigen-induced airway hyperresponsiveness, eosinophilia, and serum IgE levels. J Immunol 161, 5054-5060.
19. Kanangat, S., Thomas, J., Gangappa, S., Babu, J. S. & Rouse, B. T. (1996). Herpes simplex virus type 1-mediated up-regulation of IL-12 (p40) mRNA expression. Implications in immunopathogenesis and protection. J Immunol 156, 1110-1116.
20. Kettle, S., Alcamí, A., Khanna, A., Ehret, R., Jassoy, C. & Smith, G. L. (1997). Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1β-converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1β-induced fever. J Gen Virol 78, 677-685.
21. Kim, S. H., Reznikov, L. L., Stuyt, R. J. L., Selzman, C. H., Fantuzzi, G., Hoshino, T., Young, H. A. & Dinarello, C. A. (2001). Functional reconstitution and regulation of IL-18 activity by the IL-18Rβ chain. J Immunol 166, 148-154.
22. Kohno, K., Katakoa, J., Ohtsuki, T., Suemoto Y., Okamoto, I., Usui, M., Ikeda, M. & Kurimoto, M. (1997). IFN-γ-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J Immunol 158, 1541-1550.
23. Lauwerys, B. R., Renauld, J.-C. & Houssiau, F. A. (1999). Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18. Cytokine 11, 822-830.
24. Lauwerys, B. R., Garot, N., Renauld, J.-C. & Houssiau, F. A. (2000). Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15 or the combination of IL-12 and IL-18. J Immunol 165, 1847-1853.
25. Mahalingam, S., Farber, J. M. & Karupiah, G. (1999). The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity in vivo. J Virol 73, 1479-1491.
26. Micallef, M. J., Ohtsuki, T., Kohno, K. & 9 other authors (1996). lnterferon-γ-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-γ production. Eur J Immunol 26, 1647-1651.
27. + T cells using an ELISPOT assay. J Immunol Methods 181, 45-54.
28. Munder, M., Mallo, M., Eichmann, K. & Modolell, M. (1998). Murine macrophages secrete interferon-γ upon combined stimulation with interleukin (IL) 12 and IL-18: A novel pathway of autocrine macrophage activation. J Exp Med 187, 2103-2108.
29. Nakamura, S., Otani, T., Ijiri, Y., Motoda, R., Kurimoto, M. & Orita, K. (2000). IFN-γ-dependent and -independent mechanisms in adverse effects caused by concomitant administration of IL-18 and IL-12. J Immunol 164, 3330-3336.
30. Nakanishi, K., Yoshimoto, T., Tsutsui, H. & Okamura, H. (2001). Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 19, 423-474.
31. + effector T cells is differentially regulated by IL-18 and IL-12. J Immunol 162, 3202-3211.
32. Okamura, H., Tsutsui, H., Komatsu, T. & other authors (1995). Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378, 88-91.
33. Orange, J. S. & Biron, C. A. (1996). An absolute and restricted requirement for IL-12 in natural killer cell IFN-γ production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J Immunol 156, 1138-1142.
34. Orange, J. S., Wang, B., Terhorst, C. & Biron, C. A. (1995). Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J Exp Med 182, 1045-1056.
35. Osaki, T., Peron, J. M., Cai, Q., Okamura, H., Robbins, P. D., Kurimoto, M., Lotze, M. T. & Tahara, H. (1998). IFN-γ-inducing factor/IL-18 administration mediates IFN-γ and IL-12-independent antitumor effects. J Immunol 160, 1742-1749.
36. Ozmen, L., Aguet, M., Trinchieri, G. & Garotta, G. (1995). The in vivo antiviral activity of interleukin-12 is mediated by γ interferon. J Virol 69, 8147-8150.
37. Pien, G. C., Satoskar, A. R., Takeda, K., Akira, S. & Biron, C. A. (2000). Cutting edge: selective IL-18 requirements for induction of compartmental IFN-γ response during viral infection. J Immunol 165, 4787-4791.
38. Qureshi, M. H., Zhang, T., Koguchi, Y., Nakashima, K., Okamura, H., Kurimoto, M. & Kawakami, K. (1999). Combined effects of IL- 12 and IL-18 on the clinical course and local cytokine production in murine pulmonary infection with Cryptococcus neoformans. Eur J Immunol 29, 643-649.
39. Ramírez, J. C., Gherardi, M. M. & Esteban, M. (2000). The biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine. J Virol 74, 923-933.
40. Ramsay, A. J., Ruby, J. & Ramshaw, I. A. (1993). A case for cytokines as effector molecules in the resolution of virus infection. Immunol Today 14, 155-157.
41. Ramshaw, I. A., Ramsay, A. J., Karupiah, G., Rolph, M. S., Mahalingam, S. & Ruby, J. C. (1997). Cytokines and immunity to viral infections. Immunol Rev 159, 119-135.
42. Rodríguez, J. F., Rodríguez, D., Rodríguez, J. R., McGowan, E. B. & Esteban, M. (1988). Expression of the firefly luciferase gene in vaccinia virus: a highly sensitive gene marker to follow virus dissemination in tissues of infected animals. Proc Natl Acad Sci U S A 85, 1667-1671.
43. Rodríguez, J. R., Risco, C., Carrascosa, J. L., Esteban, M. & Rodríguez, D. (1997). Characterization of early stages in vaccinia virus membrane biogenesis: implications of the 21-kilodalton protein and a newly identified 15-kilodalton envelope protein. J Virol 71, 1821-1833.
44. Sareneva, T., Matikainen, S., Kurimoto, M. & Julkunen, I. (1998). Influenza A virus-induced IFN-α/β and IL-18 synergistically enhance IFN-γ gene expression in human T cells. J Immunol 160, 6032-6038.
45. Smith, V. P., Bryant N. A. & Alcamí, A. (2000). Ectromelia, vaccinia and cowpox viruses encode secreted interleukin-18-binding proteins. J Gen Virol 81, 1223-1230.
46. Symons, J. A., Adams, E., Tscharke, D. C., Reading, P. C., Waldmann, H. & Smith, G. L. (2002). The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model. J Gen Virol 83, 2833-2844.
47. Takeda, K., Tsutsui, H., Yoshimoto, T., Adachi, O., Yoshida, N., Kishimoto, T., Okamura, H., Nakanishi, K. & Akira, S. (1998). Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8, 383-390.
48. Tanaka-Kataoka, M. T., Kunikata, T., Takayama, S., Iwaki, K., Ohashi, K., Ikeda, M. & Kurimoto, M. (1999). In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection. Cytokine 11, 593-599.
49. - T cell subsets to express IL-18 receptor and produce IFN-γ in response to IL-18. J Immunol 160, 3759-3765.
50. van den Broek, M., Bachmann, M. F., Köhler, G., Barner, M., Escher, R., Zinkernagel, R. & Kopf, M. (2000). IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-γ and nitric oxide synthetase 2. J Immunol 164, 371-378.
51. Xiang, Y. & Moss, B. (1999). IL-18 binding and inhibition of interferon γ induction by human poxvirus-encoded proteins. Proc Natl Acad Science U S A 96, 11537-11542.
52. Yamanaka, K., Hara, I., Nagai, H., Miyake, H., Gohji, K., Micallef, M. J., Kurimoto, M., Arakawa, S. & Kamidono, S. (1999). Synergistic antitumor effects of interleukin-12 gene transfer and systemic administration of interleukin-18 in a mouse bladder cancer model. Cancer Immunol Immunother 48, 297-302.
53. Yoshimoto, T., Takeda, K., Tanaka, T. Ohkusu K., Kashiwamura, S., Okamura, H., Akira, S. & Nakanishi, K. (1998). IL-12 upregulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-γ production. J Immunol 161, 3400-3407.
54. Zhang, Y., Wang, Y., Gilmore, X., Xu, K. & Mbawuike, I. N. (2001). independent and synergistic effects of interleukin-18 And interleukin-12 in augmenting cytotoxic T lymphocyte responses and IFN-γ production in aging. J Interferon Cytokine Res 21, 843-850.
55. Zinkernagel, R. M. (1996). Immunology taught by viruses. Science 271, 173-178.